Abstract:Resumo A doença de Behçet (DB) é uma vasculite multissistêmica de etiologia desconhecida. O acometimento cardiovascular é bem descrito na literatura, sendo que a principal causa de morte na DB é secundária a complicações aneurismáticas. Relata-se aqui o caso de um paciente portador de DB com aneurisma de aorta abdominal reincidente, o qual foi corrigido por meio de endoprótese customizada. O tratamento ideal para portadores de DB ainda é bastante controverso e desafiador, tendo em vista as dificuldades técnica… Show more
“…1 It is linked with a lower likelihood of complications during the postoperative period, with incidence of around 19%. 23 Endovascular treatment is therefore proving to be a promising alternative to open surgery for treating these patients 14 and has already become the approach of choice for the majority of patients with high surgical risk. 23 Endovascular treatment generally involves shorter operating time, shorter hospital stay, and lower blood loss compared with open surgical treatment.…”
Section: Resultsmentioning
confidence: 99%
“…23 Endovascular treatment is therefore proving to be a promising alternative to open surgery for treating these patients 14 and has already become the approach of choice for the majority of patients with high surgical risk. 23 Endovascular treatment generally involves shorter operating time, shorter hospital stay, and lower blood loss compared with open surgical treatment. Furthermore, endovascular prosthesis deployment has a high success rate (90% in low risk patients and 80% patients with moderate to high risk).…”
Behçet’s Disease (BD) is a rare, chronic, relapsing, inflammatory, and multisystemic disease. There is no universally described test for confirming diagnosis, so it is made clinically, on the basis of its classic triad of signs: oral ulcers, genital ulcers, and uveitis (inflammation of the uveal tract of the eye). The aim of this study is to evaluate the importance of endovascular treatment in Behçet’s disease. The literature review conducted to achieve this objective covered 30 articles published between 2002 and 2021. Behçet’s Disease affects both the venous and arterial systems. Rupture of aneurysms is the main cause of death and thus requires treatment, which can be clinical, open surgical, or endovascular. Endovascular surgery has been gaining ground for surgical treatment of arterial aneurysms, including those related to BD, although the therapy of choice is still controversial.
“…1 It is linked with a lower likelihood of complications during the postoperative period, with incidence of around 19%. 23 Endovascular treatment is therefore proving to be a promising alternative to open surgery for treating these patients 14 and has already become the approach of choice for the majority of patients with high surgical risk. 23 Endovascular treatment generally involves shorter operating time, shorter hospital stay, and lower blood loss compared with open surgical treatment.…”
Section: Resultsmentioning
confidence: 99%
“…23 Endovascular treatment is therefore proving to be a promising alternative to open surgery for treating these patients 14 and has already become the approach of choice for the majority of patients with high surgical risk. 23 Endovascular treatment generally involves shorter operating time, shorter hospital stay, and lower blood loss compared with open surgical treatment. Furthermore, endovascular prosthesis deployment has a high success rate (90% in low risk patients and 80% patients with moderate to high risk).…”
Behçet’s Disease (BD) is a rare, chronic, relapsing, inflammatory, and multisystemic disease. There is no universally described test for confirming diagnosis, so it is made clinically, on the basis of its classic triad of signs: oral ulcers, genital ulcers, and uveitis (inflammation of the uveal tract of the eye). The aim of this study is to evaluate the importance of endovascular treatment in Behçet’s disease. The literature review conducted to achieve this objective covered 30 articles published between 2002 and 2021. Behçet’s Disease affects both the venous and arterial systems. Rupture of aneurysms is the main cause of death and thus requires treatment, which can be clinical, open surgical, or endovascular. Endovascular surgery has been gaining ground for surgical treatment of arterial aneurysms, including those related to BD, although the therapy of choice is still controversial.
“… 1 It is linked with a lower likelihood of complications during the postoperative period, with incidence of around 19%. 23 Endovascular treatment is therefore proving to be a promising alternative to open surgery for treating these patients 14 and has already become the approach of choice for the majority of patients with high surgical risk. 23 …”
Resumo A doença de Behçet (DB) é caracterizada por ser uma doença rara, crônica, recidivante, inflamatória e multissistêmica. Quanto ao diagnóstico, não existe nenhum teste universalmente descrito; logo, ele é feito de maneira clínica, por meio da presença da sua tríade clássica de sinais: úlceras orais, úlceras genitais e uveíte (inflamação do trato uveal do olho). O objetivo deste estudo foi avaliar a importância do tratamento endovascular na doença de Behçet, sendo que a revisão de literatura para obter essa resposta foi realizada a partir de 30 artigos publicados entre 2002 e 2021. A DB acomete tanto o sistema venoso quanto o arterial. A ruptura de aneurismas é a principal causa de morte e necessita de tratamento, podendo ser clínico, cirúrgico aberto ou por via endovascular. A cirurgia endovascular vem ganhando espaço no tratamento cirúrgico nos casos de aneurismas arteriais, inclusive nos relacionados com DB, apesar de a terapia de escolha ainda ser controversa.
“…Belczak et al. 7 reported successful treatment of a recurrent para-renal pseudoaneurysm secondary to initial endovascular repair of ruptured abdominal aortic aneurysm, using a CMD 4-fenestration component. Xia et al.…”
Section: Discussionmentioning
confidence: 99%
“…2–4 Endovascular treatment with adjunctive immunosuppressive therapy has been documented carrying less procedural trauma and higher survival rate than open repair, and a shift from open surgery to endovascular repair in BD has been recommended. 2,3,5–8…”
Introduction To report total endovascular treatment for a rare case of Crawford extent IV thoraco-abdominal aortic aneurysm (TAAA) using custom-designed branched device in a patient with Behçet’s disease. Methods A 50 years’ old man with history of BD was accidentally diagnosed Crawford extent IV TAAA during computed tomography follow-up after left nephrectomy of renal carcinoma. The aneurysm extended from descending aorta to right common iliac artery with a maximum diameter of 6.2 cm. Results The endovascular procedure wassuccessfully performed using custom-designed branched component to cannulate visceral arteries, bifurcated endograft and iliac legs to exclude the aneurysm sac in abdominal aorta and an iliac branched device to preserve the right internal iliac artery. The patient was discharged without any complication. Computed tomography angiogram at one month after endovascular repair demonstrated total exclusion of the aneurysm, patent visceral branches and right internal iliac artery. No complication occurred to six-month follow-up. Conclusion Endovascular treatment of stable TAAA in patients with Behc?et's disease using custom-designed branched device is feasible, microinvasive and safe. The long-term efficacy needs to be observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.